Cargando…

Correction: Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study

Detalles Bibliográficos
Autores principales:	ten Haaf, Kevin, Jeon, Jihyoun, Tammemägi, Martin C., Han, Summer S., Kong, Chung Yin, Plevritis, Sylvia K, Feuer, Eric J., de Koning, Harry J., Steyerberg, Ewout W., Meza, Rafael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518586/ https://www.ncbi.nlm.nih.gov/pubmed/32976487 http://dx.doi.org/10.1371/journal.pmed.1003403

Ejemplares similares

Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study
por: ten Haaf, Kevin, et al.
Publicado: (2017)

A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening Strategies
por: ten Haaf, Kevin, et al.
Publicado: (2019)

Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial
por: Tammemägi, Martin C., et al.
Publicado: (2019)

Comparing Benefits from Many Possible Computed Tomography Lung Cancer Screening Programs: Extrapolating from the National Lung Screening Trial Using Comparative Modeling
por: McMahon, Pamela M., et al.
Publicado: (2014)

Personalising lung cancer screening: An overview of risk‐stratification opportunities and challenges
por: ten Haaf, Kevin, et al.
Publicado: (2021)

Methods for individualized assessment of absolute risk in case-control studies should be weighted carefully
por: Haaf, Kevin Ten, et al.
Publicado: (2016)

Evaluation of benefits and harms of adaptive screening schedules for lung cancer: A microsimulation study
por: Cao, Pianpian, et al.
Publicado: (2022)

Implementation of lung cancer screening: what are the main issues?
por: van der Aalst, Carlijn M., et al.
Publicado: (2021)

Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada
por: ten Haaf, Kevin, et al.
Publicado: (2017)

Treatment capacity required for full‐scale implementation of lung cancer screening in the United States
por: Blom, Erik F., et al.
Publicado: (2019)

Racial and Ethnic Disparities in Lung Cancer Screening by the 2021 USPSTF Guidelines Versus Risk-Based Criteria: The Multiethnic Cohort Study
por: Aredo, Jacqueline V, et al.
Publicado: (2022)

Projecting the effects of tobacco control policies in the USA through microsimulation: a study protocol
por: Tam, Jamie, et al.
Publicado: (2018)

Cross-sectional Patterns and Longitudinal Transitions of Premium and Non-Premium Cigar Use in the United States
por: Jeon, Jihyoun, et al.
Publicado: (2023)

Personalised Lung Cancer Screening (PLuS) study to assess the importance of coexisting chronic conditions to clinical practice and policy: protocol for a multicentre observational study
por: Braithwaite, Dejana, et al.
Publicado: (2022)

Cost-Effectiveness Analysis of Lung Cancer Screening Accounting for the Effect of Indeterminate Findings
por: Toumazis, Iakovos, et al.
Publicado: (2019)

Systematic Review and Meta-Analysis of Community- and Choice-Based Health State Utility Values for Lung Cancer
por: Blom, Erik F., et al.
Publicado: (2020)

Associations Between E-cigarette Use and E-cigarette Flavors With Cigarette Smoking Quit Attempts and Quit Success: Evidence From a U.S. Large, Nationally Representative 2018–2019 Survey
por: Mok, Yoonseo, et al.
Publicado: (2022)

Impact of Reduced Tobacco Smoking on Lung Cancer Mortality in the United States During 1975–2000
por: Moolgavkar, Suresh H., et al.
Publicado: (2012)

Clinical prediction models: a practical approach to development, validation, and updating
por: Steyerberg, Ewout W
Publicado: (2019)

Clinical prediction models: a practical approach to development, validation, and updating
por: Steyerberg, Ewout W
Publicado: (2009)

Number and Size Distribution of Colorectal Adenomas under the Multistage Clonal Expansion Model of Cancer
por: Dewanji, Anup, et al.
Publicado: (2011)

Lung Cancer Incidence Trends by Gender, Race and Histology in the United States, 1973–2010
por: Meza, Rafael, et al.
Publicado: (2015)

Risk Model–Based Lung Cancer Screening and Racial and Ethnic Disparities in the US
por: Choi, Eunji, et al.
Publicado: (2023)

Prediction of COPD risk accounting for time-varying smoking exposures
por: Chang, Joanne T., et al.
Publicado: (2021)

Trends of Ovarian Cancer Incidence by Histotype and Race/Ethnicity in the United States 1992–2019
por: Phung, Minh Tung, et al.
Publicado: (2023)

Uptake of minimally invasive surgery and stereotactic body radiation therapy for early stage non-small cell lung cancer in the USA: an ecological study of secular trends using the National Cancer Database
por: Blom, Erik F, et al.
Publicado: (2020)

All‐cause mortality versus cancer‐specific mortality as outcome in cancer screening trials: A review and modeling study
por: Heijnsdijk, Eveline A. M., et al.
Publicado: (2019)

Trends in US Adult Smoking Prevalence, 2011 to 2022
por: Meza, Rafael, et al.
Publicado: (2023)

Feature selection and validated predictive performance in the domain of Legionella pneumophila: a comparative study
por: van der Ploeg, Tjeerd, et al.
Publicado: (2016)

Events per variable (EPV) and the relative performance of different strategies for estimating the out-of-sample validity of logistic regression models
por: Austin, Peter C, et al.
Publicado: (2014)

Clinical prediction models : a practical approach to development, validation, and updating /
por: Steyerberg, Ewout W.
Publicado: (2009)

Prognostic Index for Predicting Prostate Cancer Survival in a Randomized Screening Trial: Development and Validation
por: Neupane, Subas, et al.
Publicado: (2021)

Cost-Effectiveness of a Telephone-Based Smoking Cessation Randomized Trial in the Lung Cancer Screening Setting
por: Cao, Pianpian, et al.
Publicado: (2022)

Assessing Discriminative Performance at External Validation of Clinical Prediction Models
por: Nieboer, Daan, et al.
Publicado: (2016)

Correction: Assessing the Validity of Asthma Associations for Eight Candidate Genes and Age at Diagnosis Effects
por: Pino-Yanes, María, et al.
Publicado: (2013)

There is no such thing as a validated prediction model
por: Van Calster, Ben, et al.
Publicado: (2023)

Contemporary issues in the implementation of lung cancer screening
por: Lam, Stephen, et al.
Publicado: (2021)

Correction to: Intravenous fluids: balancing solutions
por: Hoorn, Ewout J.
Publicado: (2020)

A Cost-Effectiveness Analysis of Lung Cancer Screening With Low-Dose Computed Tomography and a Diagnostic Biomarker
por: Toumazis, Iakovos, et al.
Publicado: (2021)

Correction for Couthouis et al., A yeast functional screen predicts new candidate ALS disease genes
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_di9m0b75o0cqshrbevijf5sfdh